AstraZeneca’s former head of its China business has been formally charged by the country’s authorities with illegal trading, unlawful collection of personal information and medical insurance fraud, alongside another former employee.
Leon Wang, who has been in detention since 2024, was the drugmaker’s most senior executive in China for a decade until his arrest. AstraZeneca said in its results update this week that an unnamed “former [executive vice-president] and one former senior employee” had been charged. It later confirmed to the FT that the executive mentioned was Wang.
AstraZeneca said the two former employees would be tried at a court in Shenzhen but that a trial date had not been set.
您已阅读32%（699字），剩余68%（1470字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。